







































Surgical management of congenital chylous ascites
Ayman Albaghdady, Khaled M. El-Asmar, Mohamed Moussa
and Sameh Abdelhay
Objective The objective of this study was to present our
experience regarding the diagnosis and therapeutic
approach in cases of congenital chylous ascites that were
surgically managed in our department in a 10-year period.
Background Congenital chylous ascites is a rare condition
that constitutes a challenge for physicians. This condition is
often refractory to therapy, and it is responsible for serious
malnutrition and immunological deficiency because of
losses of proteins and lymphocytes.
Patients and methods From 2007 to 2017, four cases of
congenital chylous ascites were managed at our center. All
cases were treated surgically after failure of medical treatment.
Results The first patient had no definite lymphatic leaks
rather than presence of a moderate amount of milky ascitic
fluid with dilated lymphatics at the root of the mesentery
and at the intestinal wall and enlarged regional lymph
nodes. The second one had leaking chylolymphatic cyst in
the greater omentum that was excised. The third patient
had no definite lymphatic leaks rather than thickened
greater omentum, and thus, subtotal omentectomy was
done. The fourth baby had no definite lymphatic leaks and
developed reaccumulation of the ascitic fluid 1 month after
surgery; insertion of a peritoneovenous shunt was indicated
that succeeded to resolve the ascites. All children are
growing up normally with no recurrence of the ascites on
long-term follow-up. Ann Pediatr Surg 14:56–59 © 2018
Annals of Pediatric Surgery.
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Introduction
Congenital chylous ascites is an uncommon disease usually
caused by obstruction or rupture of the peritoneal or
retroperitoneal lymphatic glands. It is defined as the
accumulation of chyle in the peritoneal cavity in infants
younger than 3 months [1]. It is a serious disorder because
of its remarkable mechanical, nutritional, and immunologi-
cal consequences that resulted from the continuous losses
of proteins and lymphocytes [2]. Many pathological
conditions can result in this disease, including congenital
defects of the lymphatic system; nonspecific bacterial,
parasitic and tuberculous peritoneal infection; liver cirrhosis;
malignant neoplasm; blunt abdominal trauma; and surgical
injury [1]. The reported incidence of congenital chylous
ascites is reported to be 1 : 20 000–1 : 187 000 live births [3].
Though the incidence of chylous ascites has increased in
recent years, the treatment remains unsatisfactory in some
cases because of prolonged duration of disease. Conserva-
tive treatment of chylous ascites, recommended in most
patients, involves paracentesis, a medium chain triglyceride
(MCT)-based diet, total parenteral nutrition (TPN), and
recently used somatostatin therapy. Surgery is only
recommended when conservative treatment fails [2].
Usually, the MCT-based diet is the first choice. TPN is
recommended after dietary manipulation has failed, and
somatostatin therapy is attempted only if chylous ascites
has been refractory to all conservative measures. It usually
takes several weeks to 2 months to close the lymphatic
fistula adequately with routine conservative regimens [4].
Patients and methods
In this work, we retrospectively reviewed our depart-
ment experience in managing patients presented with
congenital chylous ascites during the past 10-year period.
Three cases were referred to us for surgical intervention
after failure of medical treatment, and one case was
explored for excision of huge intra-abdominal cyst.
Pediatric surgery department, Ain Shams University
ethical committee approved to retrospectively analyze
chylous ascites patients in the last 10 years.
Results
During the period between 2007 and 2017, four cases of
congenital chylous ascites were surgically managed in the
Pediatric Surgery Department, Ain Shams University
Hospital.
The first case of a male infant weighing 4.3 kg presented at
the age of 8 weeks with rapidly increasing abdominal
distention from the first week of birth. Abdomen was
grossly distended and measured 47 cm in girth with
moderate bilateral hydrocele. He was dyspneic, and
examination result of the cardiovascular and respiratory
system was normal. Serum electrolytes, urea, and creati-
nine levels were normal. Hemoglobin and total blood
count levels were normal. Total protein was 61 g/l, albumin
was 37 g/l, globulin was 24 g/l, and total bilirubin was
10mmol/l. Urine examination showed 0.1 g albumin/l.
Chest radiograph result was normal. Ultrasound (US) of the
abdomen showed large amount of fluid in the peritoneal
cavity, inferior vena cava and hepatic veins were normal,
and there was no organomegaly. Computed tomography-
abdomen showed no abnormality rather than huge amount
of intraperitoneal fluid (Fig. 1). Ascitic fluid analysis
revealed total protein 22 g/l, glucose 5mmol/l, triglycerides
more than 110mmol/l, cholesterol 19mmol/l, and lactic
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dehydrogenase165 IU/l. Cytology of the ascitic fluid
showed large number of lymphocytes. The child was
given TPN for 10 weeks. During the initial period of
treatment, paracentesis was performed to relieve dyspnea.
Introduction of high MCT milk formula was attempted;
however, the ascites did not resolve. Laparotomy revealed
presence of a moderate amount of milky ascitic fluid and
dilated lymphatics at the root of the mesentery and at the
intestinal wall with enlarged regional lymph nodes. Post-
operatively, he was given MCT formula exclusively for
4 months. As the ascites did not recur, normal diet was
gradually introduced. At 2 years of age, he was well, with
no recurrence of the ascites.
The second case was a 28-day-old full-term male baby who
presented to the emergency unit because of abdominal
colic and vomiting. Abdominal US revealed a cystic
formation (45× 32mm) near the transverse colon, and
MRI additionally showed edema of the intestinal wall. The
ascitic fluid, obtained by paracentesis, revealed 75%
lymphocytes and triglycerides of 4490mg/dl. The patient
had been subjected to exploratory laparotomy. The
peritoneal cavity was filled with milky fluid. A leaking
chylolymphatic cyst was found in the greater omentum
(Fig. 2). The mesentery was thickened with dilated
lymphatics. The cyst was completely excised with subtotal
omentectomy. The pathologic examination showed thick,
vascularized, fibrous connective tissue, consistent with
chylolymphatic cyst wall. Postoperative period was un-
eventful. On the fourth postoperative day, the patient
started MCT milk diet and discharged from the hospital
1 week later. Follow-up US (1st, 3rd, 6th, and 12th month
postoperatively) showed no ascitic fluid. The baby shifted
to breast milk fed from the seventh month of age, and he is
growing up normally for 3 years of follow-up.
The third case was a girl born prematurely at 32 weeks of
gestation by cesarean birth because of fetal ascites and
hydrops. The ascitic fluid obtained by paracentesis was
straw colored, with 8160 cells/l (85% lymphocytes).
Diagnostic evaluation including pelviabdominal US and
abdominal computed tomography showed a huge
amount of ascitic fluid, and there were no suggestive
findings of any other abnormality. Lymphoscintigraphy
failed to reveal the site of leakage. Initial treatment was
conservative, with TPN, octreotide, and multiple
abdominal paracentesis. Finally, an abdominal drainage
tube was inserted. The amount of ascetic fluid produced
was 700 ml/24 h. Surgical intervention was decided at age
of 50 days as there was no significant decrease of the
daily chyle amount. During exploratory laparotomy,
there was thickening of the greater omentum (Fig. 3)
with no other abnormalities found intraperitoneal or
retroperitoneal. Subtotal omentectomy was done, and a
drainage tube was placed in the abdominal cavity. The
amount of ascitic fluid dramatically decreased post-
operatively. The child started MCT milk diet on the
10th day postoperatively and was discharged 3 weeks
after surgery. Follow-up abdominal US at first, third, and
sixth month after discharge revealed no reaccumulation
Fig. 1
Abdominal computed tomographic findings show massive ascites
without other abdominal abnormalities.
Fig. 2
Intraoperative findings of excised greater omental cyst.
Fig. 3
Intraoperative findings of thickened greater omentum.
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of ascitic fluid. The child has normal growth and has
been fed normally since the eighth month of life with
follow-up till 4 years of age.
Our fourth case was a 9-week-old male infant weighing
4.5 kg presented with rapidly increasing abdominal
distention from the age of the 2 weeks. Abdomen was
grossly distended, and the patient was dyspneic with
normal examination of the cardiovascular and respiratory
system. Abdominal US detected a considerable amount
of ascites, and abdominal paracentesis was performed.
The analysis of evacuated ascites showed the following:
specific gravity 1.035, chylomicrons (+ ), cell count 6000/
mm3, mostly lymphocyte 82%, and monocyte 10%.
Chylous ascites was diagnosed and TPN was adminis-
tered, but the ascites persisted for 30 days. Repeated
paracenteses were mandatory, and a considerable amount
of fresh frozen plasma was given. Surgical intervention
was done and revealed presence of a copious amount of
milky fluid between the bowel loops, which was
identified by the biochemical analysis as chyle. The
intraperitoneal organs had no remarkable lesions, and the
retroperitoneal space was explored by mobilizing the left
and right colonic flexure. After doing this maneuver, a
large amount of milky fluid was released from the
retroperitoneal space; the exact source of which could not
be identified. The operation was completed by a
thorough lavage of the peritoneal cavity and the
placement of drains (right paracolic gutter and pelvic
space). After laparotomy, the patient received TPN and
intravenous octreotide for 7 days. Chyle output from the
drains was progressively diminished, and the patient was
discharged from our department after 11 days with no
postoperative complications. Patient presented after
1 month of discharge from the hospital with reaccumula-
tion of the ascitic fluid again. Reexploration was done,
and a peritoneovenous shunt (Denver Biomaterials Inc.,
Evergreen, Colorado, USA) was implanted (Fig. 4). The
vascular end tube was placed in the superior vena cava
through the right internal jugular vein. The ascites was
resolved by the fourth postoperative day. The patient
was subsequently discharged on the seventh day after
shunt implantation. The patient developed chronic
calcular cholecystitis 18 months later and was subjected
to cholecystectomy. It was noted that the ascitic fluid had
not developed for 18 months after the shunt implanta-
tion. The shunt was removed during the cholecystect-
omy surgery. There was no recurrence of ascites for
9 years of follow-up, and the patient has been doing well.
Discussion
Chylous ascites is uncommon in children. It is, however,
relatively more common in infancy [5]. Congenital
malformations of lymphatic system like congenital lym-
phangiomatosis, congenital chylous cysts, and atresia of the
lymphatic ducts are responsible for 39% of cases [6,7].
Idiopathic condition accounts for 30% of cases, and this
condition is said to have leaky lymphatics [8]. ‘Leaky
lymphatics’ appears to be caused by delayed maturation or
hypoplasia of lacteals which allows chyle to leak into the
peritoneal cavity [8,9]. Conservative and symptomatic
measures like TPN, high MCT diet, and repeated
paracentesis form the initial management. In refractory
cases, the administration of somatostatin or its analog
octreotide is needed [10–15]. It is not completely under-
stood how these drugs work in these cases. It is speculated
that they reduce the absorption of fatty acids from the
intestine and decrease the gastric, pancreatic and enteral
secretions, the intestinal motility, and the visceral blood
flow and so they decrease the production of chyle. It is also
believed that these drugs inhibit specific receptors found
in the normal lymphatic vessels of the intestinal wall, and
they prevent the excretion of lymph [11,12,15]. The aim of
conservative management is to provide time for the leaky
lymphatics to get obliterated and for new lymphovenous
channels to get established [9]. The time required for the
conservative management to be effective in congenital
chylous ascites is highly variable and may require 10 weeks
or more [16]. If the conservative treatment is not sufficient
to resolve the ascites and/or fails to provide sustained relief
after the introduction of normal diet, surgery is the
appropriate choice. It was found that 58% of children with
intractable chylous ascites have a lesion amenable to surgical
intervention [17]. In our series, there was no definite cause
in three cases rather than thickened greater omentum in
one case and greater omental leaking chylolymphatic cyst in
another case. Important for the success of the operation is to
recognize the leakage site [17]. Localization of the chyle
leaking point intraoperatively is often difficult. Preoperative
lymphangiography, lymphoid scintigraphy, or more simply
and safer the oral administration of a lipophilic dye, – for
example, Sudan Black 6 h before surgery may facilitate the
identification of the responsible site of chylous leakage
[17,18]. With the advance of imaging modalities, a
noninvasive MRI lymphangiography that allows precise
imaging of thoracic lymphatic vessels without contrast-
enhancing agents is available now in some centers [19].
Recently, localization of leaking point and lymphatic duct
ligation could be performed under laparoscopic guidance
with minimal invasiveness. Laparoscopy may have the
advantages of exploring the peritoneal cavity in its natural
state, in addition to have a magnified image of the
abdominal cavity [17,20].
When nonoperative and operative therapy fails, perito-
neovenous shunts placement is indicated with some
Fig. 4
Intraoperative findings of peritoneovenous shunt.
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success [21]. High levels of cell counts and protein
contents in the chylous ascites increase the risk of shunt
obstruction. Denver shunt has a valve mechanism,
which prevents backflow of blood, and the valve
chamber lies in the subcutaneous tissue can be
compressed to promote flow and to relieve blockage.
Other complications reported were cardiac disseminated
intravascular coagulation, and perforation of the cor-
onary sinus [22]. Sooriakumaran et al. [23] reviewed 11
children who underwent shunting over a 17-year period.
In all of the children, ascites resolved except for a child
of 4 years old with lymphohistiocytosis. They recom-
mended elective removal of the shunt after 1 year as
five shunts were removed 1–3 years after insertion
without recurrence of ascites. In the presented case,
ascites had not accumulated for 18 months, and the
shunt was still patent and functioning. Another modality
for management of refractory cases is the fibrin glue,
which has been used recently to seal the area of lymph
exudation in the abdominal cavity especially when the
exact leaking point that is amenable to suture could not
be identified [15,18,24,25].
Conclusion
Congenital chylous ascites is an uncommon pathology. It
can be suspected early with antenatal US, and the
diagnosis is confirmed postnatally by analysis of the
ascitic fluid. It is desirable to give an adequate trial of
conservative treatment specially if there is good response
as laparotomy may not always reveal a correctable
surgical abnormality. Surgery should be reserved for
those who have an identifiable surgically correctable
lesion or when conservative approach fails to provide
sustained relief after the introduction of normal diet.
When nonoperative and operative therapy fails, perito-
neovenous shunts should be considered.
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